Intrapartum Corticosteroid use Significantly Increases the Risk of Gestational Diabetes in Women with Inflammatory Bowel Disease
Open Access
- 16 February 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 9 (3) , 223-230
Abstract
Women with inflammatory bowel disease (IBD) may be at higher risk of adverse pregnancy outcomes. This study compared perinatal outcomes in women with and without IBD. The population-based Data Integration, Measurement, and Reporting (DIMR) administrative discharge database was used to identify women (≥18 years of age) in Alberta, Canada, with IBD who delivered a baby between 2006 and 2009 inclusive. Women without IBD were randomly sampled and matched in a 3:1 ratio to IBD cases by age at conception (±1 year). Odds ratios of gestational diabetes, preterm birth, low birth weight, cesarean section, and neonatal intensive care unit admission were calculated. One hundred and sixteen IBD patients were age-matched to 381 pregnant women without IBD. Gestational diabetes, preterm birth, and cesarean section were more common in women with IBD compared with controls (6.9 versus 1.8%, p = 0.03; 12.9 versus 0.3%, p < 0.0001; 43.1 versus 21.0%, p = 0.009, respectively). On multivariate analysis, women with IBD were independently more likely to have gestational diabetes (odds ratio [OR] = 4.3; 95% confidence interval [CI] 1.2–16.3), preterm birth (OR = 19.7, 95% CI 2.2–173.9), and to deliver by cesarean section (OR = 2.7, 95% CI 1.6–4.6) after adjusting for age and smoking status. Intrapartum corticosteroid use significantly increases the risk of gestational diabetes in women with IBD. Furthermore, IBD patients are at higher risk of preterm delivery and are more likely to undergo cesarean section compared with a healthy age-matched population. The finding of a higher risk of gestational diabetes is a novel finding not previously reported in the IBD literature.Keywords
This publication has 45 references indexed in Scilit:
- Smoking does influence disease behaviour and impacts the need for therapy in Crohn′s disease in the biologic eraAlimentary Pharmacology & Therapeutics, 2013
- Association of vitamin D status with socio-demographic factors in Calgary, Alberta: an ecological study using Census Canada dataBMC Public Health, 2013
- Alteration of endothelial function markers in women with gestational diabetes and their fetusesThe Journal of Maternal-Fetal & Neonatal Medicine, 2012
- Postoperative complications following colectomy for ulcerative colitis: A validation studyBMC Gastroenterology, 2012
- The Hyperglycemia and Adverse Pregnancy Outcome StudyDiabetes Care, 2012
- Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006Alimentary Pharmacology & Therapeutics, 2011
- Genetic Variants of Wnt Transcription Factor TCF-4 (TCF7L2) Putative Promoter Region Are Associated with Small Intestinal Crohn's DiseasePLOS ONE, 2009
- Inflammatory bowel disease and preterm deliveryInternational Journal of Gynecology & Obstetrics, 2005
- Glucose Tolerance and Risk of Gestational Diabetes Mellitus in Nulliparous Women Who Smoke during PregnancyAmerican Journal of Epidemiology, 2004
- Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registriesAmerican Journal of Gastroenterology, 1998